{"id":26,"date":"2026-02-19T14:18:26","date_gmt":"2026-02-19T08:48:26","guid":{"rendered":"https:\/\/mdforlives.blog\/?p=26"},"modified":"2026-02-19T18:01:54","modified_gmt":"2026-02-19T12:31:54","slug":"ertugliflozin-shows-promising-results-as-therapy-for-diabetes","status":"publish","type":"post","link":"https:\/\/mdforlives.com\/blog\/ertugliflozin-shows-promising-results-as-therapy-for-diabetes\/","title":{"rendered":"Ertugliflozin: Uses, Mechanism of Action &#038; Side Effects"},"content":{"rendered":"<p><strong>Ertugliflozin<\/strong> is an oral antidiabetic medication used for the management of type 2 diabetes mellitus (T2DM) in adults. As a sodium\u2013glucose cotransporter-2 (SGLT2) inhibitor, ertugliflozin lowers blood glucose levels by promoting urinary glucose excretion rather than increasing insulin secretion. Clinical trials and real-world evidence suggest that ertugliflozin not only improves glycaemic control but may also contribute to weight reduction and cardiovascular and renal protection. This article provides a comprehensive overview of ertugliflozin uses, mechanism of action, safety profile, dosage, side effects, and recent clinical evidence.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_74 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/mdforlives.com\/blog\/ertugliflozin-shows-promising-results-as-therapy-for-diabetes\/#What_Is_Ertugliflozin\" >What Is Ertugliflozin?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/mdforlives.com\/blog\/ertugliflozin-shows-promising-results-as-therapy-for-diabetes\/#Uses_of_Ertugliflozin_Tablet_%E2%80%93_Indications_and_Usage\" >Uses of Ertugliflozin Tablet \u2013 Indications and Usage<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/mdforlives.com\/blog\/ertugliflozin-shows-promising-results-as-therapy-for-diabetes\/#Mechanism_of_Action_%E2%80%93_How_Ertugliflozin_Works\" >Mechanism of Action \u2013 How Ertugliflozin Works<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/mdforlives.com\/blog\/ertugliflozin-shows-promising-results-as-therapy-for-diabetes\/#Ertugliflozin_Advantages_and_Disadvantages\" >Ertugliflozin Advantages and Disadvantages<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/mdforlives.com\/blog\/ertugliflozin-shows-promising-results-as-therapy-for-diabetes\/#Safety_Advice_Contraindications\" >Safety Advice (Contraindications)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/mdforlives.com\/blog\/ertugliflozin-shows-promising-results-as-therapy-for-diabetes\/#Warnings_and_Precautions\" >Warnings and Precautions<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/mdforlives.com\/blog\/ertugliflozin-shows-promising-results-as-therapy-for-diabetes\/#Interaction_With_Drugs\" >Interaction With Drugs<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/mdforlives.com\/blog\/ertugliflozin-shows-promising-results-as-therapy-for-diabetes\/#Ertugliflozin_Side_Effects_Adverse_Reactions\" >Ertugliflozin Side Effects (Adverse Reactions)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/mdforlives.com\/blog\/ertugliflozin-shows-promising-results-as-therapy-for-diabetes\/#How_to_Use_Ertugliflozin_Dosage_Administration\" >How to Use Ertugliflozin? (Dosage &amp; Administration)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/mdforlives.com\/blog\/ertugliflozin-shows-promising-results-as-therapy-for-diabetes\/#Ertugliflozin_for_the_Treatment_of_Type_2_Diabetes\" >Ertugliflozin for the Treatment of Type 2 Diabetes<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/mdforlives.com\/blog\/ertugliflozin-shows-promising-results-as-therapy-for-diabetes\/#Ertugliflozins_Recent_Studies_Clinical_Trials\" >Ertugliflozin\u2019s Recent Studies &amp; Clinical Trials<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/mdforlives.com\/blog\/ertugliflozin-shows-promising-results-as-therapy-for-diabetes\/#Conclusion\" >Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/mdforlives.com\/blog\/ertugliflozin-shows-promising-results-as-therapy-for-diabetes\/#Frequently_Asked_Questions\" >Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/mdforlives.com\/blog\/ertugliflozin-shows-promising-results-as-therapy-for-diabetes\/#Is_ertugliflozin_the_same_as_metformin\" >Is ertugliflozin the same as metformin?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/mdforlives.com\/blog\/ertugliflozin-shows-promising-results-as-therapy-for-diabetes\/#How_much_does_ertugliflozin_cost\" >How much does ertugliflozin cost?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/mdforlives.com\/blog\/ertugliflozin-shows-promising-results-as-therapy-for-diabetes\/#Can_ertugliflozin_cause_kidney_problems\" >Can ertugliflozin cause kidney problems?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/mdforlives.com\/blog\/ertugliflozin-shows-promising-results-as-therapy-for-diabetes\/#Does_ertugliflozin_cause_weight_loss\" >Does ertugliflozin cause weight loss?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n\n<h2><span class=\"ez-toc-section\" id=\"What_Is_Ertugliflozin\"><\/span><strong>What Is Ertugliflozin?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Ertugliflozin is a selective SGLT2 inhibitor approved for the treatment of adults with type 2 diabetes mellitus. It works at the level of the kidneys, targeting glucose reabsorption rather than pancreatic insulin production. This insulin-independent mechanism makes ertugliflozin particularly valuable for patients who do not achieve adequate glycaemic control with lifestyle modification or first-line therapies alone.<\/p>\n<p>In individuals with T2DM, excess glucose is filtered by the kidneys and reabsorbed back into the bloodstream. Ertugliflozin blocks this process, allowing glucose to be excreted in the urine, thereby lowering plasma glucose levels. Because its action does not rely on beta-cell function, ertugliflozin can be effective across different stages of disease progression.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Uses_of_Ertugliflozin_Tablet_%E2%80%93_Indications_and_Usage\"><\/span><strong>Uses of Ertugliflozin Tablet \u2013 Indications and Usage<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Ertugliflozin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus. Its flexibility allows it to be used in multiple therapeutic settings.<\/p>\n<p><strong>Monotherapy<\/strong><\/p>\n<p>Ertugliflozin may be prescribed alone in patients who are unable to tolerate metformin or have contraindications such as gastrointestinal intolerance or renal concerns that limit metformin use.<\/p>\n<p><strong>Combination Therapy<\/strong><\/p>\n<p>Ertugliflozin tablets are commonly used in combination with other antidiabetic agents, including:<\/p>\n<ul>\n<li>Metformin<\/li>\n<li>DPP-4 inhibitors such as sitagliptin<\/li>\n<li>Insulin (with caution)<\/li>\n<\/ul>\n<p>Combination therapy targets multiple pathophysiological mechanisms of diabetes, improving overall glycaemic outcomes while minimizing insulin dose escalation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Mechanism_of_Action_%E2%80%93_How_Ertugliflozin_Works\"><\/span><strong>Mechanism of Action \u2013 How Ertugliflozin Works<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Ertugliflozin inhibits the sodium\u2013glucose cotransporter-2 (SGLT2) protein located in the proximal renal tubules. Under normal physiological conditions, SGLT2 is responsible for reabsorbing approximately 90% of filtered glucose back into circulation.<\/p>\n<p>By blocking this transporter:<\/p>\n<ul>\n<li>Renal glucose reabsorption is reduced<\/li>\n<li>Excess glucose is excreted through urine<\/li>\n<li>Plasma glucose levels decline<\/li>\n<\/ul>\n<p>This mechanism results in:<\/p>\n<ul>\n<li>Lower fasting and postprandial glucose levels<\/li>\n<li>Reduced insulin demand<\/li>\n<li>Caloric loss contributing to modest weight reduction<\/li>\n<\/ul>\n<p>Beyond glycaemic control, SGLT2 inhibition leads to osmotic diuresis and natriuresis, which may explain observed reductions in blood pressure and cardiovascular stress.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Ertugliflozin_Advantages_and_Disadvantages\"><\/span><strong>Ertugliflozin Advantages and Disadvantages<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Potential Advantages<\/strong><\/p>\n<ul>\n<li>Insulin-independent glucose lowering<\/li>\n<li>Low intrinsic risk of hypoglycaemia<\/li>\n<li>Modest but consistent weight loss<\/li>\n<li>Reduction in systolic blood pressure<\/li>\n<li>Potential cardiovascular and renal protective effects<\/li>\n<li>Once-daily oral dosing improves adherence<\/li>\n<\/ul>\n<p><strong>Potential Disadvantages<\/strong><\/p>\n<ul>\n<li>Increased risk of genital mycotic infections<\/li>\n<li>Volume depletion and hypotension in susceptible patients<\/li>\n<li>Risk of diabetic ketoacidosis (rare but serious)<\/li>\n<li>Higher cost compared with older oral agents<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Safety_Advice_Contraindications\"><\/span><strong>Safety Advice (Contraindications)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Ertugliflozin should not be used in:<\/p>\n<ul>\n<li>Patients with type 1 diabetes mellitus<\/li>\n<li>Individuals with a history of diabetic ketoacidosis<\/li>\n<li>Patients with severe renal impairment or end-stage renal disease<\/li>\n<li>Individuals on dialysis<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Warnings_and_Precautions\"><\/span><strong>Warnings and Precautions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Clinicians should exercise caution in patients with:<\/p>\n<ul>\n<li>Moderate renal impairment<\/li>\n<li>Low blood pressure or dehydration<\/li>\n<li>Elderly patients at risk of falls<\/li>\n<li>Concurrent use of diuretics<\/li>\n<\/ul>\n<p>Patients should be educated on recognizing symptoms of dehydration, hypotension, and ketoacidosis, even when blood glucose levels appear normal.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Interaction_With_Drugs\"><\/span><strong>Interaction With Drugs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Ertugliflozin may interact with:<\/p>\n<ul>\n<li>Diuretics (enhanced volume depletion)<\/li>\n<li>Insulin or insulin secretagogues (increased hypoglycaemia risk)<\/li>\n<li>Antihypertensive medications (additive blood pressure lowering)<\/li>\n<\/ul>\n<p>Dose adjustments and careful monitoring may be required when used alongside these agents.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Ertugliflozin_Side_Effects_Adverse_Reactions\"><\/span><strong>Ertugliflozin Side Effects (Adverse Reactions)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Common Side Effects<\/strong><\/p>\n<ul>\n<li>Female genital mycotic infections<\/li>\n<li>Urinary tract infections<\/li>\n<li>Increased urination<\/li>\n<li>Dizziness or lightheadedness<\/li>\n<li>Mild hypotension<\/li>\n<\/ul>\n<p><strong>Less Common but Serious Effects<\/strong><\/p>\n<ul>\n<li>Diabetic ketoacidosis<\/li>\n<li>Acute kidney injury<\/li>\n<li>Severe dehydration<\/li>\n<\/ul>\n<p>Most adverse reactions are manageable with patient education, hydration, and early intervention.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Use_Ertugliflozin_Dosage_Administration\"><\/span><strong>How to Use Ertugliflozin? (Dosage &amp; Administration)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Recommended starting dose: 5 mg once daily<\/li>\n<li>Maximum dose: 15 mg once daily<\/li>\n<li>Can be taken with or without food<\/li>\n<li>Dose adjustments may be required based on renal function<\/li>\n<\/ul>\n<p>Patients should follow prescribing physician instructions and avoid abrupt discontinuation without medical advice.<\/p>\n<p><strong>Overdosage<\/strong><\/p>\n<p>There is limited clinical experience with ertugliflozin overdose. In suspected cases:<\/p>\n<ul>\n<li>Provide supportive care<\/li>\n<li>Monitor renal function and hydration<\/li>\n<li>Consider glucose and ketone monitoring<\/li>\n<\/ul>\n<p><strong>Quick Tips (Handling &amp; Disposal)<\/strong><\/p>\n<ul>\n<li>Store at room temperature, away from moisture<\/li>\n<li>Do not use expired tablets<\/li>\n<li>Dispose of unused medication according to local pharmaceutical waste guidelines<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Ertugliflozin_for_the_Treatment_of_Type_2_Diabetes\"><\/span><strong>Ertugliflozin for the Treatment of Type 2 Diabetes<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Ertugliflozin plays an important role in modern diabetes management by addressing hyperglycemia through renal pathways. Its benefits extend beyond glucose lowering, supporting weight control and cardiovascular risk reduction; key concerns in long-term diabetes outcomes.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Ertugliflozins_Recent_Studies_Clinical_Trials\"><\/span><strong>Ertugliflozin\u2019s Recent Studies &amp; Clinical Trials<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The VERTIS clinical trial program evaluated ertugliflozin as monotherapy and in combination therapy. Results demonstrated:<\/p>\n<ul>\n<li>Significant reductions in HbA1c<\/li>\n<li>Improvements in fasting plasma glucose<\/li>\n<li>Weight and blood pressure reduction<\/li>\n<\/ul>\n<p>More recent cardiovascular outcome analyses suggest neutral to beneficial effects on major adverse cardiovascular events, with ongoing research exploring renal protection in high-risk populations. These findings support ertugliflozin\u2019s role as part of a comprehensive diabetes management strategy.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Ertugliflozin is a well-established SGLT2 inhibitor offering effective glycaemic control with additional metabolic and cardiovascular benefits. Its insulin-independent mechanism, once-daily dosing, and expanding evidence base make it a valuable option for adults with type 2 diabetes. As with all antidiabetic therapies, individualized treatment decisions and ongoing clinical monitoring remain essential.<\/p>\n<p>Help improve diabetes care through real-world insights. Sign up for <a href=\"https:\/\/mdforlives.com\/\">MDForLives<\/a> surveys<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Is_ertugliflozin_the_same_as_metformin\"><\/span>Is ertugliflozin the same as metformin?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>No. Metformin reduces hepatic glucose production, while ertugliflozin increases renal glucose excretion. They work through entirely different mechanisms.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_does_ertugliflozin_cost\"><\/span>How much does ertugliflozin cost?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>In the United States, ertugliflozin typically costs between $400\u2013$500 per month without insurance coverage.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Can_ertugliflozin_cause_kidney_problems\"><\/span>Can ertugliflozin cause kidney problems?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>While generally renal-protective, ertugliflozin may affect kidney function in susceptible individuals. Regular renal monitoring is advised.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Does_ertugliflozin_cause_weight_loss\"><\/span>Does ertugliflozin cause weight loss?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Yes. Clinical studies show modest but consistent weight reduction associated with ertugliflozin use.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ertugliflozin is an oral antidiabetic medication used for the management of type 2 diabetes mellitus (T2DM) in adults. As a sodium\u2013glucose cotransporter-2 (SGLT2) inhibitor, ertugliflozin lowers blood glucose levels by promoting urinary glucose excretion rather than increasing insulin secretion. Clinical trials and real-world evidence suggest that ertugliflozin not only improves glycaemic control but may also contribute to weight reduction and cardiovascular and renal protection. This article provides a comprehensive overview of ertugliflozin uses, mechanism of action, safety profile, dosage, side effects, and recent clinical evidence. What Is Ertugliflozin? Ertugliflozin is a selective SGLT2 inhibitor approved for the treatment of adults&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[14],"tags":[],"class_list":["post-26","post","type-post","status-publish","format-standard","hentry","category-endocrinology"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v23.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Ertugliflozin: Uses, Mechanism of Action &amp; Side Effects<\/title>\n<meta name=\"description\" content=\"Ertugliflozin is an SGLT2 inhibitor used in type 2 diabetes. Learn its uses, mechanism of action, dosage, side effects, and cost.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mdforlives.com\/blog\/ertugliflozin-shows-promising-results-as-therapy-for-diabetes\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ertugliflozin: Uses, Mechanism of Action &amp; Side Effects\" \/>\n<meta property=\"og:description\" content=\"Ertugliflozin is an SGLT2 inhibitor used in type 2 diabetes. Learn its uses, mechanism of action, dosage, side effects, and cost.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mdforlives.com\/blog\/ertugliflozin-shows-promising-results-as-therapy-for-diabetes\/\" \/>\n<meta property=\"og:site_name\" content=\"Medical Market Research Blog | A Blog about Healthcare Survey\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/MDforLives\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-19T08:48:26+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-19T12:31:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mdforlives.com\/blog\/wp-content\/uploads\/2016\/08\/cover-image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1250\" \/>\n\t<meta property=\"og:image:height\" content=\"955\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"MDForLives\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Ertugliflozin is an SGLT2 inhibitor used in type 2 diabetes. Learn its uses, mechanism of action, dosage, side effects, and cost.\" \/>\n<meta name=\"twitter:creator\" content=\"@mdforlives\" \/>\n<meta name=\"twitter:site\" content=\"@mdforlives\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"MDForLives\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/mdforlives.com\/blog\/ertugliflozin-shows-promising-results-as-therapy-for-diabetes\/\",\"url\":\"https:\/\/mdforlives.com\/blog\/ertugliflozin-shows-promising-results-as-therapy-for-diabetes\/\",\"name\":\"Ertugliflozin: Uses, Mechanism of Action & Side Effects\",\"isPartOf\":{\"@id\":\"https:\/\/mdforlives.com\/blog\/#website\"},\"datePublished\":\"2026-02-19T08:48:26+00:00\",\"dateModified\":\"2026-02-19T12:31:54+00:00\",\"author\":{\"@id\":\"https:\/\/mdforlives.com\/blog\/#\/schema\/person\/e01110c035039a159c4de9ed6c978482\"},\"description\":\"Ertugliflozin is an SGLT2 inhibitor used in type 2 diabetes. Learn its uses, mechanism of action, dosage, side effects, and cost.\",\"breadcrumb\":{\"@id\":\"https:\/\/mdforlives.com\/blog\/ertugliflozin-shows-promising-results-as-therapy-for-diabetes\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/mdforlives.com\/blog\/ertugliflozin-shows-promising-results-as-therapy-for-diabetes\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/mdforlives.com\/blog\/ertugliflozin-shows-promising-results-as-therapy-for-diabetes\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/mdforlives.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ertugliflozin: Uses, Mechanism of Action &#038; Side Effects\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/mdforlives.com\/blog\/#website\",\"url\":\"https:\/\/mdforlives.com\/blog\/\",\"name\":\"Medical Market Research Blog | A Blog about Healthcare Survey\",\"description\":\"MDForLives\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/mdforlives.com\/blog\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/mdforlives.com\/blog\/#\/schema\/person\/e01110c035039a159c4de9ed6c978482\",\"name\":\"MDForLives\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mdforlives.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/187b3a34b26b0c9220fd4f2de6744b5d4b17b2d8582eaf5d68e347b037648de4?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/187b3a34b26b0c9220fd4f2de6744b5d4b17b2d8582eaf5d68e347b037648de4?s=96&d=mm&r=g\",\"caption\":\"MDForLives\"},\"description\":\"MDForLives is a global healthcare intelligence platform where real-world perspectives are transformed into validated insights. We bring together diverse healthcare experiences to discover, share, and shape the future of healthcare through data-backed understanding.\",\"sameAs\":[\"https:\/\/mdforlives.com\/blog\/\"],\"url\":\"https:\/\/mdforlives.com\/blog\/author\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Ertugliflozin: Uses, Mechanism of Action & Side Effects","description":"Ertugliflozin is an SGLT2 inhibitor used in type 2 diabetes. Learn its uses, mechanism of action, dosage, side effects, and cost.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mdforlives.com\/blog\/ertugliflozin-shows-promising-results-as-therapy-for-diabetes\/","og_locale":"en_US","og_type":"article","og_title":"Ertugliflozin: Uses, Mechanism of Action & Side Effects","og_description":"Ertugliflozin is an SGLT2 inhibitor used in type 2 diabetes. Learn its uses, mechanism of action, dosage, side effects, and cost.","og_url":"https:\/\/mdforlives.com\/blog\/ertugliflozin-shows-promising-results-as-therapy-for-diabetes\/","og_site_name":"Medical Market Research Blog | A Blog about Healthcare Survey","article_publisher":"https:\/\/www.facebook.com\/MDforLives","article_published_time":"2026-02-19T08:48:26+00:00","article_modified_time":"2026-02-19T12:31:54+00:00","og_image":[{"width":1250,"height":955,"url":"https:\/\/mdforlives.com\/blog\/wp-content\/uploads\/2016\/08\/cover-image.jpg","type":"image\/jpeg"}],"author":"MDForLives","twitter_card":"summary_large_image","twitter_description":"Ertugliflozin is an SGLT2 inhibitor used in type 2 diabetes. Learn its uses, mechanism of action, dosage, side effects, and cost.","twitter_creator":"@mdforlives","twitter_site":"@mdforlives","twitter_misc":{"Written by":"MDForLives","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/mdforlives.com\/blog\/ertugliflozin-shows-promising-results-as-therapy-for-diabetes\/","url":"https:\/\/mdforlives.com\/blog\/ertugliflozin-shows-promising-results-as-therapy-for-diabetes\/","name":"Ertugliflozin: Uses, Mechanism of Action & Side Effects","isPartOf":{"@id":"https:\/\/mdforlives.com\/blog\/#website"},"datePublished":"2026-02-19T08:48:26+00:00","dateModified":"2026-02-19T12:31:54+00:00","author":{"@id":"https:\/\/mdforlives.com\/blog\/#\/schema\/person\/e01110c035039a159c4de9ed6c978482"},"description":"Ertugliflozin is an SGLT2 inhibitor used in type 2 diabetes. Learn its uses, mechanism of action, dosage, side effects, and cost.","breadcrumb":{"@id":"https:\/\/mdforlives.com\/blog\/ertugliflozin-shows-promising-results-as-therapy-for-diabetes\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mdforlives.com\/blog\/ertugliflozin-shows-promising-results-as-therapy-for-diabetes\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/mdforlives.com\/blog\/ertugliflozin-shows-promising-results-as-therapy-for-diabetes\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/mdforlives.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Ertugliflozin: Uses, Mechanism of Action &#038; Side Effects"}]},{"@type":"WebSite","@id":"https:\/\/mdforlives.com\/blog\/#website","url":"https:\/\/mdforlives.com\/blog\/","name":"Medical Market Research Blog | A Blog about Healthcare Survey","description":"MDForLives","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mdforlives.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/mdforlives.com\/blog\/#\/schema\/person\/e01110c035039a159c4de9ed6c978482","name":"MDForLives","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mdforlives.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/187b3a34b26b0c9220fd4f2de6744b5d4b17b2d8582eaf5d68e347b037648de4?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/187b3a34b26b0c9220fd4f2de6744b5d4b17b2d8582eaf5d68e347b037648de4?s=96&d=mm&r=g","caption":"MDForLives"},"description":"MDForLives is a global healthcare intelligence platform where real-world perspectives are transformed into validated insights. We bring together diverse healthcare experiences to discover, share, and shape the future of healthcare through data-backed understanding.","sameAs":["https:\/\/mdforlives.com\/blog\/"],"url":"https:\/\/mdforlives.com\/blog\/author\/admin\/"}]}},"jetpack_featured_media_url":"","jetpack_likes_enabled":true,"jetpack-related-posts":[],"jetpack_shortlink":"https:\/\/wp.me\/pfwvRY-q","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/mdforlives.com\/blog\/wp-json\/wp\/v2\/posts\/26","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mdforlives.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mdforlives.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mdforlives.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mdforlives.com\/blog\/wp-json\/wp\/v2\/comments?post=26"}],"version-history":[{"count":12,"href":"https:\/\/mdforlives.com\/blog\/wp-json\/wp\/v2\/posts\/26\/revisions"}],"predecessor-version":[{"id":13952,"href":"https:\/\/mdforlives.com\/blog\/wp-json\/wp\/v2\/posts\/26\/revisions\/13952"}],"wp:attachment":[{"href":"https:\/\/mdforlives.com\/blog\/wp-json\/wp\/v2\/media?parent=26"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mdforlives.com\/blog\/wp-json\/wp\/v2\/categories?post=26"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mdforlives.com\/blog\/wp-json\/wp\/v2\/tags?post=26"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}